MTNE
MTNECIK 0002044817
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (PURR 10-K) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade MTNE commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
MTNE, a blank-check SPAC, files S-1/A for 20M units at $10.00 each, targeting $200M net raise
7 material changes detected. Sign up free to read the summary.
Latest financial statements
From 10-Q filed Aug 14, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Statements of Operations (Unaudited)
| Description | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| General and administrative expenses | 7,027,699 | 30,900 | 7,128,151 | 129,409 |
| Loss from operations | (7,027,699) | (30,900) | (7,128,151) | (129,409) |
| Interest on cash held in Trust Account | 1,233,834 | — | 1,233,834 | — |
| Net loss | (5,793,865) | (30,900) | (5,894,317) | (129,409) |
| Weighted average shares outstanding of Class A ordinary shares subject to possible redemption, basic and diluted | 13,934,066 | — | 7,005,525 | — |
| Basic and diluted net loss per share, Class A ordinary shares subject to possible redemption | (0.27) | 0.00 | (0.42) | 0.00 |
| Weighted average shares outstanding of Class A non-redeemable ordinary shares, basic and diluted | 127,473 | — | 64,088 | — |
| Basic and diluted net loss per share, Class A non-redeemable ordinary shares | (0.27) | 0.00 | (0.42) | 0.00 |
| Weighted average shares outstanding of Class B non-redeemable ordinary shares, basic and diluted | 7,062,272 | 6,666,667 | 6,865,562 | 6,666,667 |
| Basic and diluted net loss per share, Class B non-redeemable ordinary shares | (0.27) | (0.00) | (0.42) | (0.02) |
Condensed Balance Sheets
| Description | JUNE 30, 2026 (unaudited) | December 31, 2025 |
|---|---|---|
| ASSETS | ||
| Cash | 1,447,919 | — |
| Prepaid expenses | 122,995 | 31,827 |
| Total current assets | 1,570,914 | 31,827 |
| Deferred offering costs | — | 1,018,517 |
| Cash held in Trust Account | 221,233,834 | — |
| Prepaid insurance long term | 89,909 | — |
| Total Assets | 222,894,657 | 1,050,344 |
| LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT | ||
| Current liabilities: | ||
| Accounts payable | 19,119 | — |
| Promissory note related party | 300,000 | 300,000 |
| Due to related party | 813,107 | 509,158 |
| Accrued expenses | 1,168,335 | 512,925 |
| Total current liabilities | 2,300,561 | 1,322,083 |
| Deferred underwriting fees payable | 6,600,000 | — |
| Advisory fees | 6,600,000 | — |
| Deferred legal fees | 291,195 | — |
| Total liabilities | 15,791,756 | 1,322,083 |
| Commitments and Contingencies (Note 6) | ||
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 22,000,000 shares at $10.06 per share | 221,233,834 | — |
| Shareholders’ deficit | ||
| Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding | — | — |
| Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 200,000 and -0- issued and outstanding at June 30, 2026 and December 31, 2025 respectively (excluding 22,000,000 and -0- shares subject to possible redemption) | 20 | — |
| Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 7,333,334 and 7,666,667 shares issued and outstanding at June 30, 2026 and December 31, 2025 respectively (1)(2) | 733 | 767 |
| Additional paid-in capital | — | 24,233 |
| Accumulated deficit | (14,131,686) | (296,739) |
| Total shareholders’ deficit | (14,130,933) | (271,739) |
| Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit | 222,894,657 | 1,050,344 |
Condensed Statements of Cash Flows (Unaudited)
| Description | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|
| Net loss | (5,894,317) | (129,409) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Interest on cash held in Trust Account | (1,233,834) | — |
| General and administrative expenses paid directly through due to related party | 303,949 | 30,875 |
| Changes in operating assets and liabilities: | ||
| Prepaid and other assets | (181,077) | — |
| Advisory fees | 6,600,000 | — |
| Deferred legal fees | 116,195 | — |
| Accounts payable | 19,119 | 10,920 |
| Accrued expenses | 37,384 | 87,614 |
| Net cash used in operating activities | (232,581) | — |
| Cash Flows from Investing Activities | ||
| Investment of cash into Trust Account | (220,000,000) | — |
| Net cash used in investing activities | (220,000,000) | — |
| Cash Flows from Financing Activities | ||
| Proceeds from sale of Class A shares, gross | 220,000,000 | — |
| Proceeds from sale of Private Placement Shares and Warrants | 2,000,000 | — |
| Offering costs paid | (319,500) | — |
| Net cash provided by financing activities | 221,680,500 | — |
| Net increase in cash | 1,447,919 | — |
| Cash beginning of period | — | — |
| Cash end of period | 1,447,919 | — |
| Supplemental disclosure of noncash investing and financing activities: | ||
| Change in offering costs included in accrued expenses | 793,026 | 258,611 |
| Change in offering costs included in deferred legal fees | 175,000 | — |
| Deferred underwriting fees payable | 6,600,000 | — |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗